Quarterly report pursuant to Section 13 or 15(d)

Acquisitions (Tables)

v3.20.1
Acquisitions (Tables)
3 Months Ended
Mar. 31, 2020
Business Combinations [Abstract]  
Schedule of Allocation of the Fair Value of Assets Acquired and Liabilities Assumed
The Company's preliminary allocation of the fair value of assets acquired and liabilities assumed as of the acquisition date of January 23, 2020 is as follows ($ in millions):
Assets acquired and liabilities assumed
 
 
Cash and cash equivalents
 
$
2,899

Premium and related receivables
 
3,414

Short-term investments
 
403

Other current assets
 
1,158

Long-term investments
 
2,699

Restricted deposits
 
319

Property, software and equipment
 
270

Intangible assets (a)
 
7,000

Other long-term assets
 
261

Total assets acquired
 
18,423

 
 
 
Medical claims liability
 
3,962

Accounts payable and accrued expenses
 
3,142

Return of premium payable
 
238

Unearned revenue
 
223

Long-term debt (b)
 
2,055

Deferred tax liabilities (c)
 
1,537

Other long-term liabilities
 
281

Total liabilities assumed
 
11,438

 
 
 
Total identifiable net assets
 
6,985

Goodwill (d)
 
10,620

Total assets acquired and liabilities assumed
 
$
17,605


Schedule of Fair Values and Weighted Average Useful Lives for Intangible Assets Acquired
The preliminary fair values and weighted average useful lives for identifiable intangible assets acquired are as follows:
 
 
Fair Value
 
Weighted Average Useful Life (in years)
Purchased contract rights
 
$
5,200

 
 
Trade names
 
800

 
 
Provider contracts
 
700

 
 
Developed technologies
 
300

 
 
Total intangible assets acquired
 
$
7,000

 
13

Supplement Pro Forma Information
The following table presents supplemental pro forma information for the three months ended March 31, 2019 ($ in millions, except per share data):
 
 
Three Months Ended
March 31, 2019
Total revenues
 
$
25,169

Net earnings attributable to common stockholders
 
$
552

Diluted earnings per share
 
$
0.93